Vaccines for human papillomavirus infection: A critical analysis.

dc.contributor.authorNath, Amiya Kumar
dc.contributor.authorThappa, Devinder Mohan
dc.date.accessioned2012-08-16T04:13:15Z
dc.date.available2012-08-16T04:13:15Z
dc.date.issued2009-05
dc.description.abstractThis article takes a critical look at the pros and cons of human papillomavirus (HPV) vaccines. There is enough evidence to suggest that the prophylactic vaccines are efficacious in preventing various benign and malignant conditions (including cervical cancers) caused by HPV. Even though the vaccine is costly, hypothetical analysis has shown that HPV vaccination will be cost effective in the long run. Therapeutic HPV vaccines used to treat established disease are still undergoing evaluation in clinical studies, and results seem to be encouraging. Although several countries have started mandatory vaccination programs with the prophylactic HPV vaccines, conservatives have voiced concerns regarding the moral impact of such vaccination programs.en_US
dc.identifier.citationNath Amiya Kumar, Thappa Devinder Mohan. Vaccines for human papillomavirus infection: A critical analysis. Indian Journal of Dermatology, Venereology and Leprology. 2009 May-June; 75(3): 245-254.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/140344
dc.language.isoenen_US
dc.source.urihttps://www.ijdvl.com/article.asp?issn=0378-6323;year=2009;volume=75;issue=3;spage=245;epage=254;aulast=Nathen_US
dc.subjectCervarixen_US
dc.subjectGardasilen_US
dc.subjectHuman papillomavirusen_US
dc.subjectProphylacticen_US
dc.subjectTherapeuticen_US
dc.subjectVaccineen_US
dc.titleVaccines for human papillomavirus infection: A critical analysis.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijdvl2009v75n3p245.pdf
Size:
424.68 KB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: